Search Results
1
Study Matches
A Phase 2b, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Saroglitazar Magnesium in Subjects with Nonalcoholic Steatohepatitis and Fibrosis
To evaluate the effect of Saroglitazar Magnesium compared with Placebo on liver scarring in patients with NASH.
Gloriany Rivas at grivas@pennstatehealth.psu.edu or 717-531-0003, ext=320223
All
18 year(s) or older
NCT05011305
Digestive Systems & Liver Disease